US Patent 11241413 Cannabinoid lozenge formulation
All edits
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Article (+408 characters)
Article
Patent abstract
The present invention relates to a lozenge composition for controlled release of cannabinoids comprising; i) a master granule component comprising one or more solid particles and one or more cannabinoids reversibly associated with the one or more solid particles; and ii) an extragranular component blended with the master granule component comprising one or more extragranular sugar alcohols.
Edits on 15 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Ane Eriksen0
Dorthe Schackinger Boesen0
Heidi Ziegler Bruun0
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
112414130
Date of Patent
February 8, 2022
0Patent Application Number
168521330
Date Filed
April 17, 2020
0Official Website
Patent Primary Examiner
Edits on 30 Mar, 2023
Golden AI
Infobox
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 9 Feb, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11241413 Cannabinoid lozenge formulation
Infobox
Is a
Patent jurisdiction
Patent number
11241413
Date of patent
February 8, 2022
Patent application number
16852133
Date Filed
April 17, 2020
Patent primary examiner
Find more entities like US Patent 11241413 Cannabinoid lozenge formulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
